Skin cancer is almost defeated. Moderna and Merck created a personalized mRNA vaccine that reduced the risk of melanoma recurrence or death by 42%. 1,137 patients participated in the experiment after the removal of the tumor. Two years later, the disease did not return in 82.2% of those who received the new treatment. The drug is created individually for the genetics of the tumor so that the immune system recognizes and destroys cancer cells.

Skin cancer is almost defeated. Moderna and Merck created a personalized mRNA vaccine that reduced the risk of melanoma recurrence or death by 42%. 1,137 patients participated in the experiment after the removal of the tumor. Two years later, the disease did not return in 82.2% of those who received the new treatment. The drug is created individually for the genetics of the tumor so that the immune system recognizes and destroys cancer cells.